ExodusPoint Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.41M | Buy |
100,997
+71,496
| +242% | +$3.12M | 0.04% | 421 |
|
2025
Q1 | $807K | Buy |
29,501
+15,375
| +109% | +$421K | 0.01% | 919 |
|
2024
Q4 | $568K | Buy |
+14,126
| New | +$568K | ﹤0.01% | 1025 |
|
2023
Q4 | – | Sell |
-11,217
| Closed | -$156K | – | 1703 |
|
2023
Q3 | $156K | Sell |
11,217
-174,308
| -94% | -$2.42M | ﹤0.01% | 1516 |
|
2023
Q2 | $4.27M | Buy |
+185,525
| New | +$4.27M | 0.03% | 445 |
|
2022
Q4 | – | Sell |
-21,552
| Closed | -$469K | – | 1838 |
|
2022
Q3 | $469K | Buy |
+21,552
| New | +$469K | 0.01% | 1357 |
|
2020
Q4 | – | Sell |
-15,969
| Closed | -$516K | – | 2102 |
|
2020
Q3 | $516K | Buy |
+15,969
| New | +$516K | 0.01% | 939 |
|